FDA Awards Orphan Drug Designation for Brain Cancer Drug Development by Helix 51 Company

Published on December 25, 2024

for glioblastoma using oncolytic Zika virus.” Aimed at minimizing funding gaps, fast-track grants are awarded to projects that have a high